Carlyle Secured Lending Inc. trades at a 34% discount to NAV, reflecting sector-wide BDC concerns as well as dividend risk.

The surge in redemption requests from private credit funds is forcing managers to slow their expansion as they grapple with ...

U.S. equities closed mixed on Monday, as investors weighed geopolitical risks and a shortened trading week dominated by ...

The Iran War is already over a month old, and its impact on the stock market is already greater than expected. Read what ...

Explore how wage growth, inflation, gas, home prices, and rates drive consumer spending and a machine-learning S&P 500 ...

DoubleLine’s Jeffrey Sherman says ignore oil-driven inflation, focus on jobs, and position for slowdown with 5–10Y duration.

U.S.-Israel war on Iran persists, in spite of Trump's signals of potential resolution to which the market has grown ...

The de facto closure of the Strait of Hormuz has produced “the largest disruption to the global oil market in its history,” ...

Corcept Therapeutics wins early FDA approval for Lifyorli in platinum-resistant ovarian cancer, boosting growth outlook.

Capital One Financial Corporation Series J Preferred offers 6.77% yield, trading at 29.1% discount to liquidation preference.

Neumora Therapeutics is downgraded from 'Strong Buy' to 'Hold' following KOASTAL-1's failure in the MDD primary endpoint.

SPMO ETF outlook: hold rating amid earnings risk and momentum rebalance to 44% Tech. Read more macro analysis here.